Investing

Acceleration of RAD204 Phase 1 dose escalation trial

by admin
Acceleration of RAD204 Phase 1 dose escalation trial

Radiopharm Theranostics (RAD:AU) has announced Acceleration of RAD204 Phase 1 dose escalation trial

Download the PDF here.

This post appeared first on investingnews.com

Related Posts

Leadership Streamlining and Cost Reductions

June 11, 2025

Lupin Modification Trial Validates Manufacturing Scale Up

June 26, 2025

Top 4 Vanadium-producing Countries

May 30, 2025

Charbone Hydrogen Announces Updates on Units for Debts

July 18, 2025

Blue Lagoon’s Dome Mountain Joins BC’s Select List...

June 2, 2025

Top 5 Manganese Reserves by Country

May 2, 2025

Syntheia Signs Non-Binding LOI for Call Center Acquisition

May 17, 2025

Buffett Hands Over Reins, What’s Next for Berkshire’s...

May 10, 2025

Corporate Update

July 8, 2025

Prismo Metals Announces Closing of Upsized Private Placement...

July 19, 2025